– Analysis of clinical trials since 2006 identified that anti-hypertensive products have a high rate of attrition.

– How do failure rates vary by product stage of development, molecule type, and mechanism of action?

– How do other factors such as average trial duration and trial size influence the costs and risks associated with product development?

– Over the 2014–2021 forecast period, the APAC anti-hypertensive therapeutics market is expected to increase in value at a CAGR of 3.4% from $15.7 billion to just over $19.9 billion. Growth is projected to vary considerably across the four assessed markets.

– Which markets make the most significant contribution to the current market size?

– Discover trends in licensing and co-development deals concerning anti-hypertensive products and identify the major strategic consolidations that have shaped the commercial landscape.

About Us:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.